Mayo Clinic Rochester, Rochester, MN.
Mayo Clinic Rochester, Rochester, MN.
J Cardiothorac Vasc Anesth. 2020 Dec;34(12):3462-3466. doi: 10.1053/j.jvca.2020.07.052. Epub 2020 Jul 22.
Patients with systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome (APLAS) are at risk for cardiac manifestations, specifically valvular heart disease requiring valve replacement. Bioprosthetic valve endocarditis is an important cause of valve failure, and it is important to keep a wide differential, especially in patients with preexisting SLE and APLAS. In this E-challenge, 2 cases of bioprosthetic aortic valve endocarditis are presented; 1 case describes infective bacterial endocarditis on an aortic prosthesis and the second describes a patient with SLE and APLAS who developed bioprosthetic valve obstruction secondary to vegetations, consistent with nonbacterial endocarditis and thrombus. Etiologies for bioprosthetic valve obstruction and evaluation by echocardiography are explored. The comparison between these 2 cases specifically highlights the importance of keeping a wide differential in endocarditis, prosthetic valve vegetations, and bioprosthetic valve obstruction.
患有系统性红斑狼疮(SLE)和抗磷脂抗体综合征(APLAS)的患者存在心脏表现的风险,特别是需要瓣膜置换的瓣膜性心脏病。生物瓣心内膜炎是瓣膜衰竭的一个重要原因,因此需要保持广泛的鉴别诊断,特别是在存在先前 SLE 和 APLAS 的患者中。在这个电子挑战中,呈现了 2 例生物瓣主动脉瓣心内膜炎病例;1 例描述了主动脉假体上的感染性细菌性心内膜炎,第 2 例描述了 SLE 和 APLAS 患者发生生物瓣阻塞,继发于赘生物,符合非细菌性心内膜炎和血栓形成。探讨了生物瓣阻塞的病因和超声心动图评估。这 2 例病例的比较特别强调了在心内膜炎、人工瓣膜赘生物和生物瓣阻塞方面保持广泛鉴别诊断的重要性。